Drug intelligence / Profile preview

moxifloxacin + povidone iodine

Development stage
Unknown
Lead developer
Alcon
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Moxifloxacin + povidone iodine is a topical ophthalmic combination used primarily for the prophylaxis of ocular infections, especially in the context of preoperative or peri-intravitreal injection care. Moxifloxacin is a fourth-generation fluoroquinolone antibiotic that inhibits bacterial DNA gyrase and topoisomerase IV, leading to inhibition of bacterial replication and cell death. Povidone iodine is a broad-spectrum antiseptic that releases free iodine, which rapidly penetrates microbial cells and disrupts protein and nucleic acid structure, resulting in cell death. The combination aims to reduce conjunctival bacterial flora more effectively than either agent alone; some studies suggest synergistic effects in reducing ocular surface bacteria[3][6]. However, clinical trials have shown mixed results regarding whether adding moxifloxacin to povidone-iodine provides additional benefit over povidone-iodine alone for preoperative prophylaxis[1][2].

02

Targets

DNA gyraseTopo IV (Bacterial Topoisomerase IV)

Beyond the preview

Go deeper on moxifloxacin + povidone iodine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on moxifloxacin + povidone iodine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call